Reactive oxygen species (ROS) produced naturally during cellular metabolism often cause oxidative damage to cells. However, these molecules also play an important role in normal cellular signaling.

Researchers led by developmental biologist Kathy Niakan at the University of Cambridge have used base editing in human embryos to learn more about human embryonic development. By deactivating a gene ...

US private equity major Bain Capital has fully exited Pune-based Emcure Pharmaceuticals, selling its remaining 1% stake for ₹350 crore in a block deal.

Scientists studying aging may be taking an important step toward understanding how to preserve the body's cells as they grow ...

A California gene-therapy pioneer has filed for bankruptcy. Eli Lilly and Astellas have already lined up bids to buy pieces ...

Sangamo Therapeutics, a pioneering gene editing biotech company in the Bay Area, has filed for Chapter 11 bankruptcy protection and agreed to sell some of its programs and platforms to Eli Lilly and ...

NITI Aayog's Trade Watch Quarterly report says India remains competitive in generics but lags in biologics, vaccines and ...

Sangamo intends to complete asset sale transactions through a voluntary Chapter 11 reorganization, in an effort to maximize business value for ...

Fermentation startups making food colors, proteins, sweeteners and specialty ingredients are attracting investment, ...

Sangamo Therapeutics will lay off 51 members of its workforce while retaining 77 people to continue work on the programs central to Astellas and Eli Lilly’s bids. In conjunction with plans to file for ...

Despite its massive $10.5 billion size and 12-drug scope, Pfizer’s oncology deal with Innovent Biologics took less than five ...

Find out more about the wave of biotech rebranding and why a growing number of companies are choosing this path to start ...